NCT04899518View on ClinicalTrials.gov

ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

922

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

March 14, 2023

Study Completion Date

March 14, 2023

Conditions
Dry Eye
Interventions
DRUG

ALY688 Ophthalmic Solution

Ophthalmic Solution

Trial Locations (1)

98004

Allysta Pharmaceuticals, Bellevue

Sponsors
All Listed Sponsors
lead

Allysta Pharmaceutical

INDUSTRY

NCT04899518 - ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter